Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-02-04

FDA Approved: CYANOKIT — Supplemental Application (BTG INTERNATIONAL INC.)

View source ↗

Summary

FDA approved a supplemental application for Cyanokit (hydroxocobalamin) from BTG International Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyanokit (hydroxocobalamin)

Snippet

SUPPL AP for CYANOKIT (HYDROXOCOBALAMIN)